Recommendations for Ethical Review of Veterinary Clinical Trials

被引:7
|
作者
Bertout, Jessica A. [1 ]
Baneux, Philippe J. R. [2 ]
Robertson-Plouch, Carol K. [3 ]
机构
[1] Compan Anim Studies Translat Res Alliance Inc, Issaquah, WA USA
[2] Cornell Univ, Ctr Anim Resources & Educ, Ithaca, NY 14850 USA
[3] Convergence Biosci, Indianapolis, IN USA
关键词
ethical review; clinical trials; translational research; comparative medicine; medical research; drug development; one health; veterinary clinical studies committee; COMPANION ANIMALS; EPILEPSY;
D O I
10.3389/fvets.2021.715926
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Ethical review of both human and animal research is critical to ensuring that studies are conducted with due regard to the welfare and safety of enrolled subjects and to the integrity of the data. However, differences exist in laws, policies, and best practices between human and animal studies. Ethical review is required for most human studies. While the laws and standards are clear for humans and for laboratory animals, the laws and standards for clinical research for client-owned animals are not as well-defined. Here, we discuss gaps in ethical review of clinical animal research in the United States of America and propose expanded functions for veterinary clinical studies committees as a solution.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Gaps in the ethical governance of pharmaceutical clinical trials in Europe
    Bernabe, Rosemarie D. L. C.
    Dawkins-Cox, Shereen A.
    Gispen-de Wied, Christine C.
    FRONTIERS IN MEDICINE, 2025, 11
  • [42] Methodological quality and reporting of ethical requirements in clinical trials
    Ruiz-Canela, M
    de Irala-Estevez, J
    Martinez-González, MA
    Gómez-Gracia, E
    Fernández-Crehuet, J
    JOURNAL OF MEDICAL ETHICS, 2001, 27 (03) : 172 - 176
  • [43] Translating clinical trials from human to veterinary oncology and back
    Fuerdoes, Irene
    Fazekas, Judit
    Singer, Josef
    Jensen-Jarolim, Erika
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [44] Ethical challenges of clinical trials with a repurposed drug in outbreaks
    Katarzyna Klas
    Karolina Strzebonska
    Marcin Waligora
    Medicine, Health Care and Philosophy, 2023, 26 : 233 - 241
  • [45] CLINICAL-TRIALS - 2 NEGLECTED ETHICAL ISSUES
    HERXHEIMER, A
    JOURNAL OF MEDICAL ETHICS, 1993, 19 (04) : 211 - &
  • [46] ASCPRO Recommendations for the Assessment of Fatigue as an Outcome in Clinical Trials
    Barsevick, Andrea M.
    Cleeland, Charles S.
    Manning, Donald C.
    O'Mara, Ann M.
    Reeve, Bryce B.
    Scott, Jane A.
    Sloan, Jeff A.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (06) : 1086 - 1099
  • [47] IMMPACT recommendations for clinical trials: opportunities for the RDC/TMD
    Haythornthwaite, J. A.
    JOURNAL OF ORAL REHABILITATION, 2010, 37 (10) : 799 - 806
  • [48] OARSI Clinical Trials Recommendations: Design and conduct of implementation trials of interventions for osteoarthritis
    Allen, K. D.
    Bierma-Zeinstra, S. M. A.
    Foster, N. E.
    Golightly, Y. M.
    Hawker, G.
    OSTEOARTHRITIS AND CARTILAGE, 2015, 23 (05) : 826 - 838
  • [49] Implementing pharmacogenetics in clinical trials: considerations about current methodological, ethical, and regulatory challenges
    Garcia-Garcia, Irene
    Seco-Meseguer, Enrique
    Borobia, Alberto M.
    Carcas-Sansuan, Antonio J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (01) : 1 - 10
  • [50] A comparison of registered and published primary outcomes in clinical trials of opioid use disorder: ACTTION review and recommendations
    Kleykamp, Bethea A.
    Ferguson, McKenzie C.
    McNicol, Ewan
    Bixho, Ida
    Matthews, Michele
    Turk, Dennis C.
    Dworkin, Robert H.
    Strain, Eric C.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 236